DC Circ. Backs Boehringer In FTC Atty-Client Privilege Row
The D.C. Circuit refused to overturn a ruling that communications subpoenaed from Boehringer Ingelheim Pharmaceuticals Inc. during a Federal Trade Commission pay-for-delay investigation are covered by attorney-client privilege, saying Tuesday one...To view the full article, register now.
Already a subscriber? Click here to view full article